Recon: Emergent wins $235.8M US anthrax vaccine contract; FDA allows import of syphilis drugs from France amid shortage
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States